Libby Amos-Stone
Libby Amos-Stone is a regulatory lawyer and litigator in the Life Sciences practice group. She specialises in contentious disputes in the sector and has broad experience in English and EU public and administrative litigation, as well as co-ordination of multi-party cross-border actions. Ms. Amos-Stone works on product liability matters, defending large multiparty actions, and individual personal injury and product liability claims. Additionally, she represents life sciences clients in public inquiries.
Ms. Amos-Stone provides regulatory and compliance advice to clients in the pharmaceutical, medical technology, food, cosmetic, and cannabis sectors. She assists companies on strategic issues arising during the life cycle of pharmaceutical products including, clinical trials, borderline classification, regulatory data protection, pediatric and orphan rewards, market access, and investigations. She also advises companies on the boundaries of the legislation and codes of practice regarding the promotion of medicinal products and medical devices and represents clients in response to PMCPA complaints.
Ms. Amos-Stone also assists life sciences and technology companies on mHealth and related issues, including classification of digital technologies, AI and navigation of the medical device, and IVD regulatory frameworks.